[RGLS] QoQ Quarter Result on 31-Mar-2012 [#Q1]

Stock
[RGLS] Regulus Therapeutics Inc.
Announcement Date
30-Mar-2012
Financial Year
2012
Quarter
31-Mar-2012 [#Q1]
Profit Trend
QoQ- -11.51%
YoY-
Quarter Report
RGLS's Result
RGLS's Financial Summary
View:
Show?
Quarter Result
31/03/13 31/12/12 30/09/12 30/06/12 31/03/12 31/12/11 30/09/11 CAGR
Revenue 3,238 3,238 2,809 3,309 3,344 3,363 3,809 -10.25%
PBT -7,239 -6,858 -5,691 -2,621 -2,246 -1,940 -1,041 263.89%
Tax -10 18 -6 -22 1 75 4 -
NP -7,229 -6,876 -5,685 -2,599 -2,247 -2,015 -1,045 262.62%
Tax Rate - - - - - - - -
Total Cost 10,467 10,114 8,494 5,908 5,591 5,378 4,854 66.83%
Ratio Analysis
31/03/13 31/12/12 30/09/12 30/06/12 31/03/12 31/12/11 30/09/11 CAGR
NP Margin -223.26 -212.35 -202.39 -78.54 -67.19 -59.92 -27.44 304.01%
Per Share
31/03/13 31/12/12 30/09/12 30/06/12 31/03/12 31/12/11 30/09/11 CAGR
EPS -24.18 -23.03 -1,918.02 -1,293.03 -1,568.04 -2,704.70 -352.56 -83.21%
EPS Diluted -24.18 -23.00 -1,918.02 -1,293.03 -1,568.04 -2,704.70 -352.56 -83.21%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.